Aim:

to report the follow up of modifiable cardiovascular risk factors (CVRF) of patients with ischaemic heart disease in a health centre during the first year of the COVID-19 pandemic.

Materials and Methods:

observational follow-up study of an ambispective cohort in a Madrid health centre.

Subjects:

patients with CHD prior to 2020, > 45 years (n:257).

Follow up:

from 13/03/2020 to 13/03/2021.

Variables:

sociodemographic, comorbidities, blood test (BT) (LDL-c), physical examination, (blood pressure [BP] and BMI), cardiovascular events (CVE), and death during follow up. Performed over three periods: baseline period: data before the pandemic commenced. First period: 13/03/2020-13/09/2020. Second period: 14/09/2020-13/03/2021. Data collection: electronic medical record. Analysis: STATA16.

Results:

a total of 257 patients with CHD was followed up (age: 73.14±0.7; 67.3% male). CHD diagnosis seven years ago (IQR:4-14). BT in 65.6% of patients in the first time period vs 20.6% in the second time period, BP 57.5% vs 18.6% and BMI 29.5% vs 7.7%. LDL-c and BMI improved during follow up to 2.2 mg/dL and 0.6 kg/m2, respectively. Systolic and diastolic BP worsened up to 6.3 mmHg and 2.5 mmHg, respectively. A total of 7.7% and 5.8% suffered a CVE in the first and second time periods, respectively. In all nine patients died during follow up.

Conclusion:

virtually two thirds of patients with CHD had undertaken LDL-c and BP follow up in the six months since the COVID-19 pandemic started. This number decreased to one third over the year. BMI was the least evaluated variable.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )